A Lancet study published Sept. 25 indicates that few in the U.S. adult population formed antibodies against SARS-CoV-2, at least during the virus’ first wave in this country. Researchers found that, as of July, the national average of Americans with SARS-CoV-2 antibodies was 9.3%.

The researchers also observed racial and economic differences, with residents in predominantly Black and Hispanic neighborhoods two-to-three times more likely than white Americans to have antibodies; the same was true for those in poorer communities, compared to those who are wealthy.

"This research clearly confirms that despite high rates of COVID-19 in the United States, the number of people with antibodies is still low and we haven't come close to achieving herd immunity," Julie Parsonnet, M.D., one of the study’s authors. “Until an effective vaccine is approved, we need to make sure our more vulnerable populations are reached with prevention measures.”

Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…